BioCentury | Jan 15, 2021
Product Development
Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection
...OrbiMed, the series A round had participation from existing investors including Menlo Ventures, Samsara Biocapital, Illumina Ventures...
...company raised a $5.5 million seed financing led by Menlo Ventures and including Samsara BioCapital, Illumina Ventures...
...company raised a $5.5 million seed financing led by Menlo Ventures and including Samsara BioCapital, Illumina Ventures...